Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Hedge Funds Think About Oxford Immunotec Global PLC (OXFD)

Page 1 of 2

At Insider Monkey we follow around 730 of the best-performing investors and even though many of them lost money in the last several months, the history teaches us that over the long-run they still manage to beat the market, which is why it can be profitable for us to imitate their activity. Of course, even the best money managers can sometimes get it wrong, but following some of their picks gives us a better chance to outperform the crowd than picking a random stock and this is where our research comes in.

Oxford Immunotec Global PLC (NASDAQ:OXFD)’s stock has been very volatile this year and has declined by more than 10% year-to-date. Nevertheless, we decided to take a closer look at the smart money investors that are backing the company. Moreover, at the end of this article we will examine companies such as Triumph Bancorp Inc (NASDAQ:TBK), Bassett Furniture Industries Inc. (NASDAQ:BSET), and Trecora Resources (NYSE:TREC) to gather more data points.

Follow Oxford Immunotec Global Plc (NASDAQ:OXFD)
Trade (NASDAQ:OXFD) Now!

In the financial world, there are a multitude of methods shareholders use to grade stocks. A pair of the less known methods are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best investment managers can outperform the S&P 500 by a significant amount (see the details here).

With all of this in mind, we’re going to take a peek at the key action surrounding Oxford Immunotec Global PLC (NASDAQ:OXFD).

How are hedge funds trading Oxford Immunotec Global PLC (NASDAQ:OXFD)?

At the end of the third quarter, a total of 9 of the hedge funds tracked by Insider Monkey held long positions in this stock, Among these funds, Redmile Group, managed by Jeremy Green, holds the number one position in Oxford Immunotec Global PLC (NASDAQ:OXFD). Redmile Group has a $298.8 million stake in the company, comprising 6.9% of its 13F portfolio. The second most bullish fund is Brian Ashford-Russell and Tim Woolley’s Polar Capital, with a $14.2 million position; 0.3% of its 13F portfolio is allocated to the company. The remaining hedge funds and institutional investors that hold long positions encompass Anand Parekh’s Alyeska Investment Group, James E. Flynn’s Deerfield Management, and Justin John Ferayorni’s Tamarack Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!